Abstracts related to multiple myeloma once again dominated ASH and a record number of attendees were there to absorb all the information. Of the 7,000 abstracts submitted, over 1,000 pertained to...
Myeloma Research Tops ASH
read more
Linda Huguelet
Linda Huguelet was diagnosed with multiple myeloma in 2010 at the age of 46 and has been actively involved in supporting the myeloma community. She experienced several relapses and underwent various treatments over the years, including stem cell transplants and CAR-T therapy. Despite facing challenges and injuries, Linda recognizes the importance of regular exercise for her physical and mental well-being. She continues to work full-time and will attend the ASH conference for the eleventh time to stay updated on the latest myeloma treatment developments, particularly focusing on options for relapsed/refractory patients, including bi-specific therapies.
Follow Linda on X: @LindaMYELOMA
Support Group Website: Chattanooga Area Multiple Myeloma Networking Group
Precision Medicine — Is That the Future Ahead?
Being able to access each myeloma patient individually and select the treatment path that is most effective is my definition of precision medicine. While the 65th Annual American Society of...
Living Life in the Moment
2023 marks my 13th year as a myeloma patient and my 11th time to attend the American Society of Hematology (ASH) Annual Meeting and Exposition. I’ve gone through numerous treatment regimens and seen...